New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 14, 2014
08:15 EDTBCR, JNJ, COV, BSX, ZMH, MDTRepeal of medical device tax pushed by Republicans, Bloomberg says
Republicans are trying to include the repeal of a medical device excise tax that has been opposed by companies such as Medtronic (MDT) and Boston Scientific (BSX) in a package of tax breaks moving through the Senate, reported Bloomberg. Other publicly traded medical device makers include Johnson & Johnson (JNJ), Zimmer (ZMH), Covidien (COV), and C.R. Bard (BCR). Reference Link
News For MDT;BSX;JNJ;ZMH;COV;BCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 27, 2015
06:59 EDTMDTMedtronic volatility flat into Q2 and outlook
Subscribe for More Information
November 24, 2015
08:31 EDTMDTMedtronic remains a top tier performer in Med Device space, says Cowen
Subscribe for More Information
November 23, 2015
08:36 EDTBCRC.R. Bard acquisition positive, says JMP Securities
After C.R. Bard agreed to buy Liberator Medical, JMP Securities says the deal "will bring incremental reimbursement expertise, potentially open the door to other chronic disease states, increase direct contact with patients and... provide a tailwind of about 2% to sales and some EPS accretion." The firm reiterates a $207 price target and Outperform rating on C.R. Bard.
November 20, 2015
10:52 EDTJNJFDA approves new oral medication to treat multiple myeloma
Subscribe for More Information
07:28 EDTBCRLiberator Medical to be acquired by C.R. Bard for $3.35 per share
Subscribe for More Information
07:28 EDTBCRC.R. Bard to acquire Liberator Medical for roughly $181M
C.R. Bard (BCR) announced that it has entered into a definitive agreement to acquire Liberator Medical Holdings (LBMH) for $3.35 per share, or approximately $181M. This transaction is structured as a merger, has been approved by each company's board of directors, and is subject to customary closing conditions, including approval of the shareholders of Liberator and regulatory approvals. The company expects the transaction to close in the first quarter of 2016 and add approximately $70M to 2016 net sales and to be slightly accretive to adjusted cash earnings per share in 2016. The company estimates that in 2017 this acquisition will increase the organic revenue growth rate of the company and contribute between 5c-10c of adjusted cash earnings per share.
05:22 EDTMDTStocks with implied volatility movement; MDT UNH
Stocks with implied volatility movement; Medtronic (MDT) 25, UnitedHealth (UNH) 30 according to iVolatility.
November 19, 2015
16:43 EDTBSXBoston Scientific receives CE Mark for next generation WATCHMAN FLX
Boston Scientific announced that the first implants of the WATCHMAN FLX Left Atrial Appendage Closure, or LAAC, Device - the latest generation of the WATCHMAN Device - occurred in Europe following CE mark approval.
10:42 EDTBSXLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
November 18, 2015
08:11 EDTJNJIMS Health forecasts global drug spending to increase 30% by 2020 to $1.4T
Subscribe for More Information
08:11 EDTJNJAduro Biotech receives milestone payment from Janssen
Aduro Biotech (ADRO) announced that it has received a milestone payment from Janssen Biotech (JNJ) for Aduro's submission of an Investigational New Drug, or IND, Application to the FDA for ADU-741, a LADD immunotherapy product candidate for the treatment of prostate cancer. The IND will enable Janssen, Aduro's license partner for ADU-741, to initiate a multi-center Phase 1 trial to evaluate the safety and immunogenicity of intravenous administration of ADU-741 in patients with metastatic castration-resistant prostate cancer.
November 17, 2015
16:45 EDTBCRCryoLife resolves PerClot litigation with Medafor
Subscribe for More Information
16:44 EDTBCRCryoLife and C.R. Bard subsidiary enter into patent resolution
Subscribe for More Information
09:14 EDTMDTMedtronic announces FDA approval, launch of MyCareLink Smart Monitor
Subscribe for More Information
November 16, 2015
14:38 EDTJNJGenmab confirms FDA approval of Darzalex
Subscribe for More Information
13:09 EDTJNJFDA approves Darzalex to treat multiple myeloma
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use